Expanded data for VCN-01 (zabilugene almadenorepvec) in metastatic pancreatic ductal adenocarcinoma (PDAC) from the VIRAGE Phase 2b trial ...

From early word predictors to GPT-4, explore how language models have evolved—and what they mean for the future of AI and ...

UK is urged to embrace floating solar technology, claiming it could double national solar capacity, protect farmland, and ...

- Rare disease commercial veteran Mr. Grabow to lead Immix’s U.S. launch and commercial buildout for NXC-201 in relapsed/refractory AL Amyloidosis, a serious, rare, blood disease with no currently ...

Agilent Technologies Inc. (NYSE: A) today announced that the University of California has received an Agilent Research ...

Transformational $34M Capital Raise in 2025 Fuels Rapid and Aggressive Two-Phase Drill Campaign Positioning Flat for Growth Toward a Maiden Mineral Resource Estimate and Year-Round Operational ...

Alto Neuroscience, Inc. ("Alto") a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for ...

Transformational $34M Capital Raise in 2025 Fuels Rapid and Aggressive Two-Phase Drill Campaign Positioning Flat for Growth Toward a Maiden Mineral Resource Estimate and Year-Round Operational Capacit ...

Epanko Expansion Supports EcoGraf HFfree®Downstream Facilities Staged Expansion to 390,000 tpa to become Africa's Largest Planned Graphite Producer EcoGraf Limited is pleased to announce the Epanko ...